In silicoanalysis of protein/peptide-based inhalers against SARS-CoV-2

被引：3
作者：
Salman, Saad [1 ]
Shah, Fahad Hassan [2 ]
Chaudhry, Maham [1 ]
Tariq, Muniba [3 ]
Akbar, Muhammad Yasir [4 ]
Adnan, Muhammad [1 ]
机构：
[1] Univ Lahore, Dept Pharm, Islamabad Campus, Islamabad 44000, Federal, Pakistan
[2] Univ Peshawar, Ctr Biotechnol & Microbiol, Khyber Pakhtunkhwa, Pakistan
[3] Univ Lahore, Diet & Nutr Sci, Islamabad Campus, Islamabad 44000, Federal, Pakistan
[4] Quaid i Azam Univ, Dept Bioinformat, Islamabad 44000, Federal, Pakistan
来源：
FUTURE VIROLOGY | 2020年 / 15卷 / 09期
关键词：
COVID-19; dornase-alfa; inhalers; monoclonal antibody; short-palate-lung and nasal-epithelial clone-1-derived peptides; DELIVERY; LUNG;
D O I：
10.2217/fvl-2020-0119
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Aim:Peptide/protein-based inhalers are excessively used to treat respiratory disorders. The molecular docking was performed for these inhalers including human neutralizing S230 light chain-antibody (monoclonal antibodies [mAbs]), alpha-1-antitrypsin (AAT), short-palate-lung and nasal-epithelial clone-1-derived peptides (SPLUNC1) and dornase-alfa (DA) against spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to assess their inhibitory activity.Materials & methods:HawkDock was used to dock these biologics against SARS-CoV-2 spike-glycoprotein.Results:Results showed that DA, AAT and mAb were quite active against spike glycoprotein with a binding free energy of -26.35 and -22.94 kcal/mol.Conclusion:mAB and AAT combined with DA can be used in the treatment of coronavirus disease of 2019 as a potential anti-SARS-CoV-2 agent.
引用
收藏
页码：557 / 564
页数：8
相关论文
共 31 条
  • [1] PULMONARY DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS
    ADJEI, A
    GUPTA, P
    [J]. JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) : 361 - 373
  • [2] Agu RU, 2001, RESP RES, V2, P198
  • [3] Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
    Baig, Abdul Mannan
    Khaleeq, Areeba
    Ali, Usman
    Syeda, Hira
    [J]. ACS CHEMICAL NEUROSCIENCE, 2020, 11 (07): : 995 - 998
  • [4] Dornase Alfa Ototoxic Effects in Animals and Efficacy in the Treatment of Clogged Tympanostomy Tubes in Children A Preclinical Study and a Randomized Clinical Trial
    Chan, Kenny H.
    Allen, Gregory C.
    Kelley, Peggy E.
    Streubel, Sven-Olrik
    Friedman, Norman R.
    Yoon, Patricia
    Gao, Dexiang
    Ruiz, Amanda G.
    Jung, Timothy T. K.
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (09) : 776 - 780
  • [5] Regulation of protein-ligand binding affinity by hydrogen bond pairing
    Chen, Deliang
    Oezguen, Numan
    Urvil, Petri
    Ferguson, Colin
    Dann, Sara M.
    Savidge, Tor C.
    [J]. SCIENCE ADVANCES, 2016, 2 (03):
  • [6] Emerging coronaviruses: Genome structure, replication, and pathogenesis
    Chen, Yu
    Liu, Qianyun
    Guo, Deyin
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (04) : 418 - 423
  • [7] Monoclonal antibodies in type 2 asthma: a systematic review and network meta-analysis
    Edris, Ahmed
    De Feyter, Silke
    Maes, Tania
    Joos, Guy
    Lahousse, Lies
    [J]. RESPIRATORY RESEARCH, 2019, 20 (01)
  • [8] Covid-19-Navigating the Uncharted
    Fauci, Anthony S.
    Lane, H. Clifford
    Redfield, Robert R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (13) : 1268 - 1269
  • [9] Inhaled protein/peptide-based therapies for respiratory disease
    Robert C. Fellner
    Shawn T. Terryah
    Robert Tarran
    [J]. Molecular and Cellular Pediatrics, 3 (1)
  • [10] Gasteiger E, 2005, The Proteomics Protocols Handbook, P571, DOI [10.1385/1-59259-890-0:571, 10.1385/1592598900]
1234